Medical device licence · 76418 · Class 2
BETA-2 MICROGLOBULIN
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed February 20, 2008; ended November 21, 2023. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 76418
- Licence holder
- Roche Diagnostics GmbhMannheim, Germany
- Risk class
- Class II (low to moderate risk)
- Licence type
- Test Kit
- First licensed
- February 20, 2008
- Ended
- November 21, 2023
- Devices covered
- 4
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- B2MG TINA-QUANT BETA2-MICROGLOBULIN
- B2MG TINA-QUANT BETA2-MICROGLOBULIN FOR ROCHE/HITACHI COBAS C/COBAS C 701
- HITACHI B2 MICROGLOBULIN
- HITACHI TINA-QUANT B2 MICROGLOBULIN
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.